Drug Stock Lifted by New Collaboration

Eton Pharmaceuticals is linking up with Xellia Pharmaceuticals

Managing Editor
Jan 21, 2020 at 10:06 AM
facebook X logo linkedin


In the biotech sphere today, the big news is a co-promotional agreement between drugmakers Eton Pharmaceuticals Inc (NASDAQ:ETON) and privately held Xellia Pharmaceuticals. The two companies will team up to promote Biorphen, Eton's Food and Drug Administration (FDA) approved blood pressure treatment. 

In response, Eton stock is up 3.2% to trade at $7.37. The shares have spent the start of 2020 consolidating below $7.50, with their 20-day moving average cushioning pullbacks below. Since a Sept. 5 bottom of $5.13, ETON has now tacked on 44%.

There hasn't been a peep from the analyst community in response to the agreement. But that may be because most analysts are firmly entrenched in the bullish camp, with all three in coverage doling out "buy" ratings. Plus, the consensus 12-month price target of $16.83 is a 135.7% premium to Friday's closing perch at $7.14. 
 

*SPONSORED CONTENT*

How to collect 1 dividend check every day for LIFE

Did you know you could collect 1 dividend check every day the market is open? You could also do it starting with just $605! For me, I'm collecting 70 dividend checks every quarter…which averages around 1.1 dividend checks every business day. There's no trading behind this... no penny stocks or high-risk investments. All you do is buy and hold and you're set. There's no set up required either. If you start buying the dividend stocks I show you today... you could collect 1 dividend per day starting as early as this week. Click here for all the details.

*SPONSORED CONTENT*